1-(5-ETHYLPYRIMIDIN-2-YL)PIPERIDIN-4-YL METHANESULFONATE, 90.0%, 2g

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole, 96.0%, 10g

2-((2,5-Dichlorophenyl)amino)-4-methyl-1,3-thiazole-5-carboxylic acid, 95%, 2g

Tazarotenic acid, 99.57%, 100mg

3-Methoxythioanisole, 98.0%, 100g

Glass packaging wool 11 µm, glass packaging according to DIN 1259-1, 500 g, plastic packaging.

1-(Oxazol-2-yl)ethanone, 95.0%, 100mg

4,4,5,5-Tetramethyl-2-(3-methylthiophen-2-yl)-1,3,2-dioxaborolane, 95.0%, 10g

1-Butylnaphthalene, 95.00%, 1g

(2-(Piperidin-1-ylmethyl)phenyl)boronic acid, 95.0%, 5g

2,3,4,5-Tetrahydro-1H-1,5-methanobenzo[d]azepine hydrochloride, 95.0%, 5g

ISOINDOLIN-5-OL HYDROCHLORIDE, 97.0%, 250mg

5-Bromo-2-methyl-8-quinolinamine, 97%, 10g